Canada Pension Plan Investment Board
NAGE

Canada Pension Plan Investment Board’s Niagen Bioscience NAGE Stock Holding History

Canada Pension Plan Investment Board’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-45,500
Closed -$201K – 1891
2026
Q1 		$201K Sell
45,500
-17,200
-27% -$92.9K ﹤0.01% 1569
2025
Q4 		$399K Buy
+62,700
New +$436K ﹤0.01% 1395
2021
Q2 		– Sell
-208,000
Closed -$1.94M – 1397
2021
Q1 		$1.94M Buy
+208,000
New +$1.65M ﹤0.01% 873

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Canada Pension Plan Investment Board's NAGE Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Niagen Bioscience (NAGE) in Q2 2026, closing a stake of 45,500 shares — an estimated $201K sold.

Canada Pension Plan Investment Board first reported a position in NAGE in Q1 2021 and held it in 3 quarters. The position peaked at $1.94M in Q1 2021. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Canada Pension Plan Investment Board reported no remaining Niagen Bioscience position as of Q2 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 45,500 Niagen Bioscience shares in Q2 2026, an estimated $201K.
  • Canada Pension Plan Investment Board first reported a position in Niagen Bioscience in Q1 2021 and held it in 3 quarters.
  • Canada Pension Plan Investment Board's Niagen Bioscience position peaked at $1.94M in Q1 2021.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.